These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35384518)

  • 21. DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma.
    Zighelboim I; Reinhart AJ; Gao F; Schmidt AP; Mutch DG; Thaker PH; Goodfellow PJ
    Cancer; 2011 Apr; 117(7):1446-53. PubMed ID: 21425145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
    Baillard P; Genestie C; Croce S; Descotes F; Rouleau E; Treilleux I; Gouy S; Morice P; Ray-Coquard I; McCluggage WG; Devouassoux-Shisheboran M
    Am J Surg Pathol; 2021 Feb; 45(2):223-229. PubMed ID: 32910017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
    Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
    JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predominant
    Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
    Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
    [No Abstract]   [Full Text] [Related]  

  • 27.
    Hurdogan O; Yilmaz I; Bay SB; Vural S; Tugcu D; Kebudi R; Gun F; Ozkan B; Bilgic B; Firat P; Yilmazbayhan D; Ozluk Y
    Pediatr Dev Pathol; 2020; 23(3):204-209. PubMed ID: 31603374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DICER1-associated central nervous system sarcoma with neural lineage differentiation: a case report.
    Yao K; Duan Z; Feng J; Yan C; Qi X
    Diagn Pathol; 2022 Sep; 17(1):72. PubMed ID: 36153506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.
    Klein S; Lee H; Ghahremani S; Kempert P; Ischander M; Teitell MA; Nelson SF; Martinez-Agosto JA
    J Med Genet; 2014 May; 51(5):294-302. PubMed ID: 24676357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent primary intracranial sarcoma, DICER1-mutant in a pediatric patient with DICER1 syndrome: the importance of molecular testing.
    Lachance A; Dimentberg E; Huang S; Bergeron-Gravel S; Bouffet É; Fonseca A; Crevier L; Saikali S; Bourget C; Giannakouros P; Faury D; Jabado N; Foulkes WD; Larouche V; Renzi S
    Childs Nerv Syst; 2024 Jun; 40(6):1965-1969. PubMed ID: 38478067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree.
    Fernández-Martínez L; Villegas JA; Santamaría Í; Pitiot AS; Alvarado MG; Fernández S; Torres H; Paredes Á; Blay P; Balbín M
    BMC Cancer; 2017 Feb; 17(1):146. PubMed ID: 28222777
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Solarski M; Rotondo F; Foulkes WD; Priest JR; Syro LV; Butz H; Cusimano MD; Kovacs K
    Endocr Relat Cancer; 2018 Mar; 25(3):R197-R208. PubMed ID: 29330195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry.
    Schultz KA; Harris A; Messinger Y; Sencer S; Baldinger S; Dehner LP; Hill DA
    Fam Cancer; 2016 Jan; 15(1):105-10. PubMed ID: 26289771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Spectrum of DICER1 Mutations in Adult-onset Thyroid Nodules with Indeterminate Cytology.
    Chong AS; Nikiforov YE; Condello V; Wald AI; Nikiforova MN; Foulkes WD; Rivera B
    J Clin Endocrinol Metab; 2021 Mar; 106(4):968-977. PubMed ID: 33460435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
    Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
    JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary intracranial sarcomas with DICER1 mutation often contain prominent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1.
    Lee JC; Villanueva-Meyer JE; Ferris SP; Sloan EA; Hofmann JW; Hattab EM; Williams BJ; Guo H; Torkildson J; Florez A; Van Ziffle J; Onodera C; Grenert JP; Cho SJ; Horvai AE; Jones DTW; Pfister SM; Koelsche C; von Deimling A; Korshunov A; Perry A; Solomon DA
    Acta Neuropathol; 2019 Mar; 137(3):521-525. PubMed ID: 30649606
    [No Abstract]   [Full Text] [Related]  

  • 38. Nasal chondromesenchymal hamartomas arise secondary to germline and somatic mutations of DICER1 in the pleuropulmonary blastoma tumor predisposition disorder.
    Stewart DR; Messinger Y; Williams GM; Yang J; Field A; Schultz KA; Harney LA; Doros LA; Dehner LP; Hill DA
    Hum Genet; 2014 Nov; 133(11):1443-50. PubMed ID: 25118636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
    Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
    Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma.
    Wasserman JD; Sabbaghian N; Fahiminiya S; Chami R; Mete O; Acker M; Wu MK; Shlien A; de Kock L; Foulkes WD
    J Clin Endocrinol Metab; 2018 May; 103(5):2009-2015. PubMed ID: 29474644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.